Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Stahel
R A
RA
Clinic and Policlinic of Oncology, University Hospital of Zürich, Switzerland.
Weder
W
W
Lievens
Y
Y
Felip
E
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008654:Mesothelioma / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D010166:Palliative Care; D010997:Pleural Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D011013:Pneumonectomy; D011878:Radiotherapy; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D013906:Thoracoscopy; D016896:Treatment Outcome
D014408:Biomarkers, Tumor